| Literature DB >> 24891029 |
Po Lai Yau1, Esther H Kang, David C Javier, Antonio Convit.
Abstract
OBJECTIVE: To ascertain whether pediatric obesity without clinically significant insulin resistance (IR) impacts brain structure and function.Entities:
Mesh:
Year: 2014 PMID: 24891029 PMCID: PMC4114991 DOI: 10.1002/oby.20801
Source DB: PubMed Journal: Obesity (Silver Spring) ISSN: 1930-7381 Impact factor: 5.002
Demographic and Endocrine Data
| Measures | Obese (n = 30) | Lean (n = 30) | Effect Size | |
|---|---|---|---|---|
| Age (yr) | 17.64 ± 1.62 (14.89–20.76) | 17.22 ± 1.55 (14.28–20.21) | 0.27 | 0.30 |
| Gender | 17 F / 13 M | 19 F / 11 M | −0.13 | 0.61 |
| Socioeconomic status | 1.96 ± 1.12 | 2.20 ± 1.15 | −0.28 | 0.40 |
| School grade | 11.87 ± 1.67 | 11.47 ± 1.84 | −0.10 | 0.42 |
| Ethnicity (White, Hispanic, African American, Asian) | 6 / 15 / 6 / 3 | 5 / 13 / 8 / 4 | ||
| BMI (kg/m2) | 35.47 ± 5.88 | 21.12 ± 2.18 | −0.86 | <0.001 |
| Waist measurement (cm) | 106.82 ± 13.33 | 75.93 ± 6.19 | 2.97 | <0.001 |
| HOMA-IR index | 1.95 ± 0.86 | 1.40 ± 0.69 | −0.30 | 0.02 |
| Glucose (mg/dL) | 74.93 ± 6.37 | 75.83 ± 6.85 | −0.06 | 0.64 |
| Insulin ( | 10.56 ± 4.71 | 7.49 ± 3.53 | 0.74 | 0.01 |
| HbA1C (%) | 5.33 ± 0.33 | 5.24 ± 0.25 | −0.18 | 0.17 |
| HDL (mg/dL) | 45.90 ± 9.31 | 54.93 ± 11.64 | −0.86 | 0.002 |
| LDL (mg/dL) | 102.97 ± 25.47 | 90.50 ± 22.80 | 0.52 | 0.05 |
| Triglycerides (mg/dL) | 79.13 ± 32.53 | 69.03 ± 28.61 | −0.20 | 0.11 |
| Systolic BP (mm Hg) | 113.27 ± 12.80 | 100.93 ± 9.17 | −0.51 | <0.001 |
| Diastolic BP (mm Hg) | 67.40 ± 9.93 | 63.07 ± 7.33 | −0.23 | 0.08 |
| CRP (mg/L) | 3.06 ± 2.46 | 0.88 ± 1.69 | −0.59 | <0.001 |
| Self-rating of sleep apnea | 0.20 ± 0.16 | 0.15 ± 0.11 | −0.14 | 0.27 |
| Beck Depression Inventory score | 9.45 ± 7.17 | 7.28 ± 7.06 | −0.18 | 0.18 |
| IPAQ total score (MET-mins/week) | 4873.14 ± 3563.48 | 4233.54 ± 2384.29 | −0.05 | 0.71 |
Normally distributed continuous variables were evaluated with the t-test (effect size Cohen’s d) unless indicated otherwise.
The Mann-Whitney U test was used (effect size r: 0.1, small; 0.3, medium; 0.5, large).
Adjusted for unequal variances (t-test)
The chi-square test was used for categorical variables.
Note: Clinical cutoffs for abnormal values – HOMA-IR > 3.99; fasting glucose > 100 mg/dL; fasting insulin > 22 μIU/mL; HbA1C ≥ 5.7%; HDL < 40 mg/dL; LDL ≥ 130/110 mg/dL; triglycerides > 110 mg/dL; systolic/diastolic BP, for those 18 years of age ≥ 90th percentile for age, gender, and height; for those over 18 years of age, systolic BP ≥ 130 mmHg or diastolic BP ≥ 85mmHg; CRP > 3 mg/L.
Cognitive Data
| Measures | Obese (n = 30) | Lean (n = 30) | Effect Size | |
|---|---|---|---|---|
| Estimated full-scale IQ | 102.56 ± 11.49 | 107.44 ± 13.18 | −0.40 | 0.15 |
| WRAT arithmetic standard score | 96.04 ± 11.02 | 103.52 ± 13.82 | −0.60 | 0.03 |
| WRAT spelling standard score | 101.71 ± 12.10 | 106.81 ± 11.46 | −0.28 | 0.04 |
| WRAT reading standard score | 106.61 ± 12.13 | 107.85 ± 9.44 | −0.11 | 0.68 |
| WRAML general index | 103.30 ± 12.79 | 106.61 ± 12.52 | −0.26 | 0.32 |
| WRAML verbal index score | 105.37 ± 12.14 | 104.29 ± 11.57 | 0.09 | 0.73 |
| WRAML visual index score | 102.52 ± 10.32 | 100.31 ± 12.98 | 0.19 | 0.48 |
| WRAML working memory index | 100.17 ± 15.57 | 107.69 ± 13.96 | −0.51 | 0.06 |
| Trails B time (s) | 64.56 ± 21.17 | 55.31 ± 15.68 | 0.50 | 0.08 |
| TOL excess moves | 16.77 ± 13.15 | 12.32 ± 7.01 | −0.13 | 0.33 |
| WCST perseverative errors | 10.85 ± 8.39 | 9.96 ± 5.56 | −0.01 | 0.92 |
| Stroop interference score | 0.07 ± 7.32 | −2.00 ± 6.02 | 0.31 | 0.24 |
| COWAT total score | 34.39 ± 8.27 | 38.97 ± 14.71 | −0.38 | 0.15 |
| WRAML attention-concentration index | 101.40 ± 13.65 | 108.86 ± 15.94 | −0.50 | 0.06 |
| Trails A time (s) | 28.14 ± 8.91 | 24.04 ± 7.27 | −0.23 | 0.08 |
| DVT total time | 396.43 ± 128.12 | 358.58 ± 72.33 | −0.17 | 0.22 |
| DSST total score | 60.19 ± 10.57 | 65.89 ± 12.20 | −0.50 | 0.07 |
Normally distributed continuous variables were evaluated with the t-test (effect size Cohen’s d) unless indicated otherwise.
COWAT, Controlled Oral Word Association Test; DVT, Digit Vigilance Test; DSST, Digit Symbol Substitution Test; TOL, Tower of London Test; WCST, Wisconsin Card Sorting Test; WRAML, Wide Range Assessment of Memory and Learning; WRAT, Wide Range Achievement Test.
The Mann-Whitney U test was used (effect size r: 0.1, small; 0.3, medium; 0.5, large).
Adjusted for unequal variances (t-test).
Scores more than 3 SDs within the group mean were excluded.
Brain Data
| Measures | Obese (n = 26) | Lean (n = 27) | Effect Size | |
|---|---|---|---|---|
| ICV volume (cc) | 1198.98 ± 99.31 | 1209.62 ± 118.91 | −0.10 | 0.73 |
| Overall CSF volume | 31.83 ± 19.22 | 30.39 ± 10.82 | −0.06 | 0.64 |
| Hippocampal volume | 2.96 ± 0.36 | 2.94 ± 0.38 | 0.11 | 0.71 |
| PFC volume | 313.73 ± 45.96 | 305.61 ± 42.32 | 0.43 | 0.14 |
| OFC gray matter volume | 27.52 ± 2.73 | 28.34 ± 2.84 | −0.39 | 0.17 |
| ACC gray matter volume | 8.28 ± 1.47 | 8.53 ± 1.21 | −0.18 | 0.52 |
| Whole brain cortical thickness | 2.46 ± 0.08 | 2.47 ± 0.07 | −0.13 | 0.64 |
| Total OFC cortical thickness | 2.76 ± 0.14 | 2.83 ± 0.10 | −0.55 | 0.05 |
| Total ACC cortical thickness | 2.83 ± 0.15 | 2.90 ± 0.16 | −0.52 | 0.07 |
All brain data are residualized to the ICV volume. For ease of interpretation, raw values for the descriptive data are presented (volumes are expressed in cc and cortical thickness in mm).
Normally distributed continuous variables were evaluated with the t-test (effect size Cohen’s d); otherwise,
the Mann-Whitney U test was used (effect size r: 0.1, small; 0.3, medium; 0.5, large).